Thyropath Labs Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 4.55 M
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 4.00 M
About Thyropath Labs
Thyropath Labs Private Limited (TLPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 December 2015 (Nine years and two months 12 days old ). Its registered office is in Nalgonda, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 4.55 M.
The company currently has active open charges totaling ₹4.00 M.
Gowri Kadimi, Bixapathy Mudda, Mohan Yanala, and One other member serve as directors at the Company.
Company Details
-
Location
Nalgonda, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85191TG2015PTC102029
-
Company No.
102029
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Dec 2015
-
Date of AGM
05 Aug 2016
-
Date of Balance Sheet
31 Mar 2016
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Thyropath Labs?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gowri Kadimi
|
Additional Director | 11-Apr-2016 | Current |
|
Bixapathy Mudda
|
Director | 03-Dec-2015 | Current |
|
Mohan Yanala
|
Additional Director | 11-Apr-2016 | Current |
|
Rasheed Shaik
|
Director | 03-Dec-2015 | Current |
Financial Performance of Thyropath Labs.
Enhance accessibility to Thyropath Labs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Thyropath Labs?
Unlock access to Thyropath Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Sneha Chemicals Private LimitedGowri Kadimi is a mutual person
-
Diagnopath Medical Labs Private Limited
Rasheed Shaik is a mutual person
Charges (Loans)
₹0.40 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 May 2016 | State Bank Of India | ₹4.00 M | Open |
How Many Employees Work at Thyropath Labs?
Unlock and access historical data on people associated with Thyropath Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Thyropath Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Thyropath Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.